TITLE

Different patterns of heparin resistance: therapeutic implications

AUTHOR(S)
Ranucci, M; Isgrò, G; Cazzaniga, A; Ditta, A; Boncilli, A; Cotza, M; Carboni, G; Brozzi, S
PUB. DATE
May 2002
SOURCE
Perfusion;May2002, Vol. 17 Issue 3, p199
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Heparin resistance (HR) during cardiac operations is a common feature. Its aetiology often recognizes a decrease in circulating antithrombin III (AT III) due to a preoperative heparin treatment. Nevertheless, some papers highlighted the existence of HR in patients with normal values of AT III. This paper was designed in order to identify this subgroup of AT III-independent heparin-resistant patients. Five hundred consecutive patients scheduled for coronary revascularization with cardiopulmonary bypass were enrolled in this prospective trial. HR was identified in 104 (20.8%) patients. Thirty-six of them (7.2% of the total population) had a preoperative AT III activity ≥100%, and were defined as AT III-independent heparin-resistant patients. This subgroup significantly differs from the AT III-dependent heparin-resistant group being affected by a less severe degree of HR and including less patients pretreated with heparin. Unlike the other heparinresistant patients, these subjects do not respond to AT III supplementation aimed at reaching supranormal AT III activity values.
ACCESSION #
6747078

 

Related Articles

  • Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Ranucci, M.; Isgrο, G.; Cazzaniga, A.; Soro, G.; Menicanti, L.; Frigiola, A. // Perfusion;1999, Vol. 14 Issue 6, p437 

    Heparin resistance (HR) is a common event in cardiac operations. At present, no clear recognition of the risk factors for HR has been reached. The aim of this study was to determine a predictive model for HR, based on the preoperative patient's profile. Two hundred consecutive patients scheduled...

  • Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery. Belboul, A.; Al-Khaja, N. // Perfusion;1997, Vol. 12 Issue 6, p385 

    To evaluate whether the effect of heparin coating the extracorporeal circuit resulted in differences in patient outcome and haemostatic alteration, 24 patients undergoing elective, isolated coronary artery bypass were randomized prospectively to cardiopulmonary bypass (CPB) with heparin-coated...

  • Heparin-bonded circuits without a cardiotomy: a description of a minimally invasive technique of cardiopulmonary bypass. Lilly, Kevin J; O'Gara, Paul J; Treanor, Patrick R; Crowley, Richard; Reardon, Deborah L; Shapira, Oz M; Khuri, Shukri F; Aldea, Gabriel S; Shemin, Richard J // Perfusion;Mar2002, Vol. 17 Issue 2, p95 

    The deleterious effects of cardiotomy suction have been well recognized and well documented for some time. The use of cardiotomy suction results in the exposure of blood to the defoaming sock, aspiration of stagnant pericardial blood into the systemic circulation, and the entrainment of both...

  • Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: part I - the effects of heparin, protamine and propofol. Gao, F.; Harris, D.; Sapsed-Bryne, S.; Sharp, S. // Perfusion;1997, Vol. 12 Issue 3, p163 

    Neurone-specific enolase (NSE) and Sangtec 100 (S-100) (Sangtec Medical, Sweden) assays are designed for clotted samples, but when studying cerebral damage following cardiac surgery, perioperative samples will contain heparin and/or protamine. The lipid emulsion propofol is also frequently used...

  • Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. Wendel, H.P.; Scheule, A.M.; Eckstein, F.S.; Ziemer, G. // Perfusion;1999, Vol. 14 Issue 1, p21 

    Extracorporeal circulation (ECC) in paediatric patients with heparin-coated oxygenation systems is rarely investigated. The objective of this study was to evaluate, preclinically, the haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. We compared 16 paediatric...

  • protamine sulfate.  // Davis's Drug Guide for Nurses, 10th edition;2007, p1005 

    The article presents information on protamine sulfate, an anti-heparin and antidote for the acute management of severe heparin overdose. The drug is used in neutralizing heparin received during dialysis, cardiopulmonary bypass and other procedures. Some of its adverse reactions or side effects...

  • Heparin.  // Reactions Weekly;11/17/2012, Issue 1428, p20 

    The article describes the case of a 59-year-old man who developed heparin resistance after receiving heparin for open heart surgery for the treatment of acute anterior myocardial infarction (MI).

  • Australasian perfusion incident survey. Jenkins, O.F.; Morris, R.; Simpson, J.M. // Perfusion;1997, Vol. 12 Issue 5, p279 

    An anonymous postal survey about perfusion accidents, incidents and safety procedures was conducted retrospectively in all identifiable cardiac surgery units in Australia and New Zealand over an 18-month period from January 1994 to July 1995. Responses were received from 69% of all eligible...

  • Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Ross, J.K.; Monro, J.L.; Manners, J.M.; Edwards, J.C.; Lewis, B.; Hyde, I.; Conway, N.; Johnson, A.M. // British Medical Journal;12/18/1976, Vol. 2 Issue 6050, p1485 

    Examines cardiac surgery in Wessex, England. Revision on the open-heart procedures carried out in the country; Use of conventional normothermic perfusion in adults; Rate of mortality in cardiac surgery.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics